GTPase and adenylate cyclase desensitize at different rates in NG108-15 cells

L Vachon, T Costa and A Herz

The time course of opioid receptor binding disappearance and loss of responsiveness of the opioid-controlled GTPase and adenylate cyclase were compared in membranes derived from NG108-15 cells pretreated with the opioid peptide agonist [D-Ala2,D-Leu5]enkephalin (DADLE). Upon pretreatment with DADLE, a rapid desensitization of the opioid- stimulated GTPase occurred with a time course distinguishable as two exponential components having respective half-lives of 5-9 and 60-80 min. Opioid receptor binding activity, as assessed using [3H]diprenorphine, also decayed as two exponential components whose half-lives were similar to those for GTPase desensitization (7 and 120 min). However, when [3H]diprenorphine binding was measured in the presence of sodium and GTP, only the second, slow component was apparent. In contrast, desensitization of the opioid-controlled adenylate cyclase occurred as only one exponential decaying process, displaying a half-life of 57 min. Whereas the loss of responsiveness of GTPase to DADLE was entirely accounted for by a reduction in the maximal stimulation produced acutely by DADLE, desensitization of adenylate cyclase was characterized by both a decrease in maximal inhibition and a shift to the right of the EC50 of the agonist in inhibiting acutely the enzyme. In addition, after 1 hr of pretreatment with DADLE, the opioid-stimulated GTPase was desensitized by 65%, whereas 80% of maximal inhibition of adenylate cyclase could still be achieved. We suggest that: the rapid loss of responsiveness of the opioid-GTPase system results from an uncoupling between the receptor and the nucleotide-binding regulatory protein (N); the fast decaying GTPase activity appears to be not directly related to the opioid- mediated inhibition of adenylate cyclase; and the slow decaying GTPase activity, as well as the desensitization of the opioid-adenylate cyclase, is most likely accounted for by down-regulation of the opioid receptor. These findings may indicate that part of the opioid- stimulated GTPase in the membrane is not involved in inhibition of the cyclase and could reflect the activity of a regulatory protein which couples opioid receptors to another membrane effector. Alternatively, they might be interpreted on the basis of a model which involves a tight coupling between receptor activation and N protein and a large amplification mechanism between N protein and adenylate cyclase.

Volume 31, Issue 2, pp. 159-168, 02/01/1987
Copyright © 1987 by American Society for Pharmacology and Experimental Therapeutics

This article has been cited by other articles:

				F. Spadaro, C. Ramoni, D. Mezzanzanica, S. Miotti, P. Alberti, S. Cecchetti, E. Iorio, V. Dolo, S. Canevari, and F. Podo Phosphatidylcholine-Specific Phospholipase C Activation in Epithelial Ovarian Cancer Cells Cancer Res., August 15, 2008; 68(16): 6541 - 6549. [Abstract] [Full Text] [PDF]

				R. Del Carmine, P. Molinari, M. Sbraccia, C. Ambrosio, and T. Costa "Induced-Fit" Mechanism for Catecholamine Binding to the {beta}2-Adrenergic Receptor Mol. Pharmacol., August 1, 2004; 66(2): 356 - 363. [Abstract] [Full Text] [PDF]

				P. Molinari, C. Ambrosio, D. Riitano, M. Sbraccia, M. C. Gro, and T. Costa Promiscuous Coupling at Receptor-Galpha Fusion Proteins. THE RECEPTOR OF ONE COVALENT COMPLEX INTERACTS WITH THE alpha -SUBUNIT OF ANOTHER J. Biol. Chem., April 25, 2003; 278(18): 15778 - 15788. [Abstract] [Full Text] [PDF]

				D. A. Eisinger, H. Ammer, and R. Schulz Chronic Morphine Treatment Inhibits Opioid Receptor Desensitization and Internalization J. Neurosci., December 1, 2002; 22(23): 10192 - 10200. [Abstract] [Full Text] [PDF]

				C. Ambrosio, P. Molinari, S. Cotecchia, and T. Costa Catechol-Binding Serines of beta 2-Adrenergic Receptors Control the Equilibrium between Active and Inactive Receptor States Mol. Pharmacol., January 1, 2000; 57(1): 198 - 210. [Abstract] [Full Text]

				H. Ammer and R. Schulz Adenylyl Cyclase Supersensitivity in Opioid-Withdrawn NG108-15 Hybrid Cells Requires Gs but Is Not Mediated by the Gsalpha Subunit J. Pharmacol. Exp. Ther., August 1, 1998; 286(2): 855 - 862. [Abstract] [Full Text]

				H. Ammer and R. Schulz Enhanced Stimulatory Adenylyl Cyclase Signaling during Opioid Dependence Is Associated with a Reduction in Palmitoylated Gsalpha Mol. Pharmacol., December 1, 1997; 52(6): 993 - 999. [Abstract] [Full Text]

				H. Ammer and R. Schulz Chronic Morphine Treatment Increases Stimulatory Beta-2 Adrenoceptor Signaling in A431 Cells Stably Expressing the Mu Opioid Receptor J. Pharmacol. Exp. Ther., January 1, 1997; 280(1): 512 - 520. [Abstract] [Full Text]